ELI LILLY AND COMPANY Financing Cash Flow
ELI LILLY AND COMPANY (LLY) reported Financing Cash Flow of $4.96 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- ELI LILLY AND COMPANY net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $8.43B.
- ELI LILLY AND COMPANY net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$3.47B, a 351.45% decline year-over-year.
- ELI LILLY AND COMPANY net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$2.88B.
- ELI LILLY AND COMPANY net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $530.80M, a 151.21% increase year-over-year.
- ELI LILLY AND COMPANY net cash provided by (used in) financing activities for fiscal 2025 was -$2.21B, a 279.92% decline from fiscal 2024.
- ELI LILLY AND COMPANY net cash provided by (used in) financing activities for fiscal 2024 was $1.23B, a 64.82% decline from fiscal 2023.
- ELI LILLY AND COMPANY net cash provided by (used in) financing activities for fiscal 2023 was $3.50B.
- ELI LILLY AND COMPANY net cash provided by (used in) financing activities for fiscal 2022 was -$5.41B.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.43B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.96B 10-Q · filed 2026-08-05 | $2.08B derived: sum of 3 quarters · filed 2026-08-05 | $2.61B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$3.47B 10-Q · filed 2026-04-30 | -$6.35B derived: sum of 2 quarters · filed 2026-04-30 | -$5.82B derived: sum of 3 quarters · filed 2026-04-30 | -$7.06B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$2.88B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$2.35B derived: sum of 2 quarters · filed 2026-02-12 | -$3.59B derived: sum of 3 quarters · filed 2026-08-05 | -$2.21B 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | $530.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$714.20M derived: sum of 2 quarters · filed 2026-08-05 | $665.80M 10-Q · filed 2025-10-30 | $440.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$1.25B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $135.00M 10-Q · filed 2026-08-05 | $134.80M 10-Q · filed 2025-08-07 | -$90.50M derived: sum of 3 quarters · filed 2026-08-05 | $120.80M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | $1.38B 10-Q · filed 2026-04-30 | $1.38B 10-Q · filed 2025-05-01 | $1.15B derived: sum of 2 quarters · filed 2026-04-30 | $1.37B derived: sum of 3 quarters · filed 2026-04-30 | $2.92B derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | -$225.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$14.20M derived: sum of 2 quarters · filed 2026-02-12 | $1.54B derived: sum of 3 quarters · filed 2026-02-12 | $1.23B 10-K · filed 2026-02-12 | $1.23B 10-K · filed 2025-02-19 | |||
| 2024-09-30 | $211.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.77B derived: sum of 2 quarters · filed 2025-10-30 | $1.46B 10-Q · filed 2025-10-30 | $5.00B derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | $1.56B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.24B 10-Q · filed 2025-08-07 | $4.79B derived: sum of 3 quarters · filed 2026-02-12 | $5.36B derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | -$311.30M 10-Q · filed 2025-05-01 | $3.23B derived: sum of 2 quarters · filed 2026-02-12 | $3.81B derived: sum of 3 quarters · filed 2026-02-12 | $2.77B derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | $3.55B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $4.12B derived: sum of 2 quarters · filed 2026-02-12 | $3.08B derived: sum of 3 quarters · filed 2026-02-12 | $3.50B 10-K · filed 2026-02-12 | $3.50B 10-K · filed 2024-02-21 | |||
| 2023-09-30 | $572.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$461.40M derived: sum of 2 quarters · filed 2024-10-30 | -$49.10M 10-Q · filed 2024-10-30 | -$1.19B derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-06-30 | -$1.03B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$621.10M 10-Q · filed 2024-08-08 | -$1.76B derived: sum of 3 quarters · filed 2025-02-19 | -$3.03B derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-03-31 | $412.30M 10-Q · filed 2024-04-30 | -$729.10M derived: sum of 2 quarters · filed 2025-02-19 | -$1.99B derived: sum of 3 quarters · filed 2025-02-19 | -$2.12B derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2022-12-31 | -$1.14B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | -$2.40B derived: sum of 2 quarters · filed 2025-02-19 | -$2.53B derived: sum of 3 quarters · filed 2025-02-19 | -$5.41B 10-K · filed 2025-02-19 | ||||
| 2022-09-30 | -$1.26B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.39B derived: sum of 2 quarters · filed 2023-11-02 | -$4.27B 10-Q · filed 2023-11-02 | -$5.79B derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | -$123.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$3.00B 10-Q · filed 2023-08-08 | -$4.53B derived: sum of 3 quarters · filed 2024-02-21 | -$4.99B derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | -$2.88B 10-Q · filed 2023-04-27 | -$4.40B derived: sum of 2 quarters · filed 2024-02-21 | -$4.87B derived: sum of 3 quarters · filed 2024-02-21 | -$5.95B derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | -$1.53B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$1.99B derived: sum of 2 quarters · filed 2024-02-21 | -$3.07B derived: sum of 3 quarters · filed 2024-02-21 | -$4.13B 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | -$463.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$1.55B derived: sum of 2 quarters · filed 2022-11-01 | -$2.60B 10-Q · filed 2022-11-01 | -$3.90B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | -$1.08B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$2.14B 10-Q · filed 2022-08-04 | -$3.43B derived: sum of 3 quarters · filed 2023-02-22 | -$3.71B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | -$1.06B 10-Q · filed 2022-04-29 | -$2.35B derived: sum of 2 quarters · filed 2023-02-22 | -$2.63B derived: sum of 3 quarters · filed 2023-02-22 | -$4.30B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | -$1.29B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$1.57B derived: sum of 2 quarters · filed 2023-02-22 | -$3.24B derived: sum of 3 quarters · filed 2023-02-22 | -$3.14B 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | -$279.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$1.95B derived: sum of 2 quarters · filed 2021-10-27 | -$1.85B 10-Q · filed 2021-10-27 | -$2.96B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | -$1.67B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$1.57B 10-Q · filed 2021-08-03 | -$2.68B derived: sum of 3 quarters · filed 2022-02-23 | -$4.37B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $106.70M 10-Q · filed 2021-04-30 | -$1.01B derived: sum of 2 quarters · filed 2022-02-23 | -$2.70B derived: sum of 3 quarters · filed 2022-02-23 | -$3.59B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | -$1.11B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$2.81B derived: sum of 2 quarters · filed 2022-02-23 | -$3.69B derived: sum of 3 quarters · filed 2022-02-23 | -$2.32B 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | -$1.69B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | -$2.58B derived: sum of 2 quarters · filed 2020-10-28 | -$1.21B 10-Q · filed 2020-10-28 | -$2.85B derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-30 | -$885.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $482.00M 10-Q · filed 2020-07-31 | -$1.16B derived: sum of 3 quarters · filed 2021-02-17 | -$725.00M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-31 | $1.37B 10-Q · filed 2020-05-01 | -$271.90M derived: sum of 2 quarters · filed 2021-02-17 | $160.80M derived: sum of 3 quarters · filed 2021-02-17 | -$670.60M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2018-12-31 | -$1.64B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | -$1.21B derived: sum of 2 quarters · filed 2021-02-17 | -$2.04B derived: sum of 3 quarters · filed 2021-02-17 | -$5.90B 10-K · filed 2021-02-17 | ||||
| 2018-09-30 | $432.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | -$398.70M derived: sum of 2 quarters · filed 2019-10-25 | -$4.27B 10-Q · filed 2019-10-25 | -$4.81B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | -$831.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$4.70B 10-Q · filed 2019-08-02 | -$5.24B derived: sum of 3 quarters · filed 2020-02-19 | -$4.74B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | -$3.87B 10-Q · filed 2019-05-02 | -$4.41B derived: sum of 2 quarters · filed 2020-02-19 | -$3.91B derived: sum of 3 quarters · filed 2020-02-19 | -$2.85B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | -$542.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$41.60M derived: sum of 2 quarters · filed 2020-02-19 | $1.02B derived: sum of 3 quarters · filed 2020-02-19 | $142.60M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $500.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.56B derived: sum of 2 quarters · filed 2018-11-06 | $684.90M 10-Q · filed 2018-11-06 | $1.07B derived: sum of 4 quarters · filed 2019-10-24 | ||||
| 2017-06-30 | $1.06B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | $184.20M 10-Q · filed 2018-07-25 | $569.40M derived: sum of 3 quarters · filed 2019-10-24 | -$30.70M derived: sum of 4 quarters · filed 2019-10-24 | ||||
| 2017-03-31 | -$875.70M 10-Q · filed 2018-04-27 | -$490.50M derived: sum of 2 quarters · filed 2019-10-24 | -$1.09B derived: sum of 3 quarters · filed 2019-10-24 | -$511.30M derived: sum of 4 quarters · filed 2019-10-24 | ||||
| 2016-12-31 | $385.20M derived: 8-K 12 month − 10-Q 9 month · filed 2019-10-24 | -$214.90M derived: sum of 2 quarters · filed 2019-10-24 | $364.40M derived: sum of 3 quarters · filed 2019-10-24 | -$559.80M 8-K · filed 2019-10-24 | ||||
| 2016-09-30 | -$600.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | -$20.80M derived: sum of 2 quarters · filed 2017-10-27 | -$945.00M 10-Q · filed 2017-10-27 | -$834.60M 10-Q · filed 2016-10-28 | -$1.82B derived: sum of 4 quarters · filed 2018-02-20 | |||
| 2016-06-30 | $579.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | -$344.90M 10-Q · filed 2017-07-28 | -$237.00M 10-Q · filed 2016-07-28 | -$1.22B derived: sum of 3 quarters · filed 2018-02-20 | -$1.81B derived: sum of 4 quarters · filed 2018-02-20 | |||
| 2016-03-31 | -$924.20M 10-Q · filed 2017-05-01 | -$816.40M 10-Q · filed 2016-04-29 | -$1.80B derived: sum of 2 quarters · filed 2018-02-20 | -$2.39B derived: sum of 3 quarters · filed 2018-02-20 | -$3.33B derived: sum of 4 quarters · filed 2018-02-20 | |||
| 2015-12-31 | -$871.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | -$1.47B derived: sum of 2 quarters · filed 2018-02-20 | -$2.41B derived: sum of 3 quarters · filed 2018-02-20 | -$3.11B 10-K · filed 2018-02-20 | -$2.92B 10-K · filed 2016-02-19 | |||
| 2015-09-30 | -$595.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$1.54B derived: sum of 2 quarters · filed 2016-10-28 | -$2.24B 10-Q · filed 2016-10-28 | -$702.50M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-06-30 | -$943.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$1.64B 10-Q · filed 2016-07-28 | -$107.30M derived: sum of 3 quarters · filed 2017-02-21 | -$513.20M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-03-31 | -$701.20M 10-Q · filed 2016-04-29 | $835.90M derived: sum of 2 quarters · filed 2017-02-21 | $430.00M derived: sum of 3 quarters · filed 2017-02-21 | -$272.50M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2014-12-31 | $1.54B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $1.13B derived: sum of 2 quarters · filed 2017-02-21 | $428.70M derived: sum of 3 quarters · filed 2017-02-21 | -$166.40M 10-K · filed 2017-02-21 | -$75.10M 10-K · filed 2015-02-19 | |||
| 2014-09-30 | -$405.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | -$1.11B derived: sum of 2 quarters · filed 2015-10-30 | -$1.70B 10-Q · filed 2015-10-30 | -$2.74B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | -$702.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$1.30B 10-Q · filed 2015-07-30 | -$2.33B derived: sum of 3 quarters · filed 2016-02-19 | -$2.86B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | -$595.10M 10-Q · filed 2015-04-30 | -$1.63B derived: sum of 2 quarters · filed 2016-02-19 | -$2.16B derived: sum of 3 quarters · filed 2016-02-19 | -$2.69B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | -$1.04B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$1.57B derived: sum of 2 quarters · filed 2016-02-19 | -$2.10B derived: sum of 3 quarters · filed 2016-02-19 | -$3.83B 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | -$529.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | -$1.06B derived: sum of 2 quarters · filed 2014-10-29 | -$2.79B 10-Q · filed 2014-10-29 | -$4.06B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-06-30 | -$533.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-28 | -$2.26B 10-Q · filed 2014-07-28 | -$3.53B derived: sum of 3 quarters · filed 2015-02-19 | -$4.07B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-03-31 | -$1.73B 10-Q · filed 2014-04-28 | -$3.00B derived: sum of 2 quarters · filed 2015-02-19 | -$3.54B derived: sum of 3 quarters · filed 2015-02-19 | -$4.09B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2012-12-31 | -$1.27B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | -$1.81B derived: sum of 2 quarters · filed 2015-02-19 | -$2.36B derived: sum of 3 quarters · filed 2015-02-19 | -$4.42B 10-K · filed 2015-02-19 | ||||
| 2012-09-30 | -$544.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$1.10B derived: sum of 2 quarters · filed 2013-10-30 | -$3.15B 10-Q · filed 2013-10-30 | -$3.81B derived: sum of 4 quarters · filed 2014-02-19 | ||||
| 2012-06-30 | -$552.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | -$2.61B 10-Q · filed 2013-07-26 | -$3.26B derived: sum of 3 quarters · filed 2014-02-19 | -$3.70B derived: sum of 4 quarters · filed 2014-02-19 | ||||
| 2012-03-31 | -$2.06B 10-Q · filed 2013-04-26 | -$2.71B derived: sum of 2 quarters · filed 2014-02-19 | -$3.15B derived: sum of 3 quarters · filed 2014-02-19 | -$3.71B derived: sum of 4 quarters · filed 2014-02-19 | ||||
| 2011-12-31 | -$650.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19 | -$1.09B derived: sum of 2 quarters · filed 2014-02-19 | -$1.66B derived: sum of 3 quarters · filed 2014-02-19 | -$2.37B 10-K · filed 2014-02-19 | ||||
| 2011-09-30 | -$440.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-26 | -$1.01B derived: sum of 2 quarters · filed 2012-10-26 | -$1.72B 10-Q · filed 2012-10-26 | -$2.27B derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | -$564.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | -$1.28B 10-Q · filed 2012-07-27 | -$1.83B derived: sum of 3 quarters · filed 2013-02-21 | -$2.22B derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | -$713.80M 10-Q · filed 2012-04-30 | -$1.26B derived: sum of 2 quarters · filed 2013-02-21 | -$1.66B derived: sum of 3 quarters · filed 2013-02-21 | -$2.19B derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | -$549.60M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | -$943.40M derived: sum of 2 quarters · filed 2013-02-21 | -$1.47B derived: sum of 3 quarters · filed 2013-02-21 | -$2.02B 10-K · filed 2013-02-21 | ||||
| 2010-09-30 | -$393.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$925.30M derived: sum of 2 quarters · filed 2011-10-28 | -$1.47B 10-Q · filed 2011-10-28 | -$2.60B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2010-06-30 | -$531.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29 | -$1.08B 10-Q · filed 2011-07-29 | -$2.21B derived: sum of 3 quarters · filed 2012-02-24 | -$3.12B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2010-03-31 | -$547.00M 10-Q · filed 2011-04-29 | -$1.68B derived: sum of 2 quarters · filed 2012-02-24 | -$2.59B derived: sum of 3 quarters · filed 2012-02-24 | -$3.70B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2009-12-31 | -$1.13B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24 | -$2.04B derived: sum of 2 quarters · filed 2012-02-24 | -$3.15B derived: sum of 3 quarters · filed 2012-02-24 | -$5.53B 10-K · filed 2012-02-24 | ||||
| 2009-09-30 | -$913.20M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-10-29 | -$2.02B derived: sum of 2 quarters · filed 2010-10-29 | -$4.41B 10-Q · filed 2010-10-29 | -$108.00M derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2009-06-30 | -$1.11B derived: 10-Q/A 6 month − 10-Q 3 month · filed 2010-08-02 | -$3.49B 10-Q/A · filed 2010-08-02 | $805.20M derived: sum of 3 quarters · filed 2011-02-22 | $239.40M derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2009-03-31 | -$2.38B 10-Q · filed 2010-07-30 | $1.92B derived: sum of 2 quarters · filed 2011-02-22 | $1.35B derived: sum of 3 quarters · filed 2011-02-22 | |||||
| 2008-12-31 | $4.30B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-22 | $3.73B derived: sum of 2 quarters · filed 2011-02-22 | $2.35B 10-K · filed 2011-02-22 | |||||
| 2008-09-30 | -$565.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-30 | -$1.95B 10-Q · filed 2009-10-30 | ||||||
| 2008-06-30 | -$1.39B 10-Q · filed 2009-07-31 | |||||||
| 2007-12-31 | -$844.90M 10-K · filed 2010-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |